BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 287195)

  • 1. Penicillamine induced membranous glomerulonephritis.
    Neild GH; Gärtner HV; Bohle A
    Scand J Rheumatol Suppl; 1979; (28):79-90. PubMed ID: 287195
    [No Abstract]   [Full Text] [Related]  

  • 2. [Perimembranous glomerulonephritis after treatment with D-penicillamine. Report on 31 cases (author's transl)].
    Gärtner HV; Neild GH; Bohle A; Hallauer W; Hoppe-Seyler G; Lüttgen FM; Schollmeyer P
    Klin Wochenschr; 1975 Sep; 53(17):835-7. PubMed ID: 1195663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Membranous glomerulonephritis caused by D-penicillamine].
    Bécares Lozano MM; Pascual Izuel JM; Mateos Sánchez A; Delgado Martínez J; Querol Prieto R; Flores Corral T
    Rev Clin Esp; 1982 Mar; 164(6):411-2. PubMed ID: 7111809
    [No Abstract]   [Full Text] [Related]  

  • 4. Membranous glomerulopathy associated with captopril therapy.
    Textor SC; Gephardt GN; Bravo EL; Tarazi RC; Fouad FM; Tubbs R; McMahon JT
    Am J Med; 1983 Apr; 74(4):705-12. PubMed ID: 6340493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiglomerular basement membrane glomerulonephritis following D-penicillamine-associated nephrotic syndrome.
    Bindi P; Gilson B; Aymard B; Noël LH; Wieslander J
    Nephrol Dial Transplant; 1997 Feb; 12(2):325-7. PubMed ID: 9132654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glomerulopathy due to D-penicillamine--clinical findings and renal biopsy].
    Brass H; Genth E; Hartl PW; Bauerdick H; Buss H; Lapp H; Heintz R
    Med Welt; 1976 Nov; 27(45):2151-3. PubMed ID: 994834
    [No Abstract]   [Full Text] [Related]  

  • 7. [Penicillamine-induced glomerulonephritis].
    Koall W; Mampel E
    Z Urol Nephrol; 1977 Jan; 70(1):13-7. PubMed ID: 848141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranous glomerulopathy and nephrotic syndrome after captopril therapy.
    Sturgill BC; Shearlock KT
    JAMA; 1983 Nov; 250(17):2343-5. PubMed ID: 6355523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune complex nephritis with nephrotic syndrome following D-penicillamine therapy].
    Hallauer W; Gärtner HV; Kronenberg KH; Manz G
    Schweiz Med Wochenschr; 1974 Mar; 104(12):434-8. PubMed ID: 4820540
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal renal vasculitis and minimal change glomerulonephritis complicating treatment with penicillamine. Report on two cases.
    Falck HM; Törnroth T; Kock B; Wegelius O
    Acta Med Scand; 1979; 205(1-2):133-8. PubMed ID: 760401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrotic syndrome presumable caused by an complex glomerulonephritis (author's transl)].
    Seelig HP; Seelig R; Fischer K; Maurer R; Safer A; Schnitzlein W
    Res Exp Med (Berl); 1977 Apr; 169(1):35-55. PubMed ID: 141075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal glomerulitis due to penicillamine.
    Hayslett JP; Bensch KG; Kashgarian M; Rosenberg LE
    Lab Invest; 1968 Oct; 19(4):376-81. PubMed ID: 5699118
    [No Abstract]   [Full Text] [Related]  

  • 13. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of D-penicillamine administration to rats, induction of renal changes: preliminary communication.
    Batsford SR; Rohrbach R; Riede UN; Sandritter W; Kluthe R
    Clin Nephrol; 1976 Sep; 6(3):394-7. PubMed ID: 991466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: D-penicillamine-induced membranous glomerulonephritis.
    Neild GH; Gärtner HV; Bohle A
    Lancet; 1975 May; 1(7917):1201-2. PubMed ID: 48830
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic glomerulonephritis and the nephrotic syndrome induced in rats with N,N'-diacetylbenzidine.
    Harman JW
    J Pathol; 1971 Jun; 104(2):119-28. PubMed ID: 5111051
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glomerulopathy in rheumatic patients due to penicillamine].
    Muller V; Krumhaar I; Schneider W; Ditscherlein G
    Allerg Immunol (Leipz); 1976; 22(3):291-5. PubMed ID: 139094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of diffuse membranous changes with remission of nephrotic syndrome.
    Osawa G; Kinoshita Y; Morita T; Soda T; Wada J
    Tohoku J Exp Med; 1976 Oct; 120(2):177-90. PubMed ID: 982435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-penicillamine induced crescentic glomerulonephritis: report and review of the literature.
    Devogelaer JP; Pirson Y; Vandenbroucke JM; Cosyns JP; Brichard S; Nagant de Deuxchaisnes C
    J Rheumatol; 1987 Oct; 14(5):1036-41. PubMed ID: 3430507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine.
    Sadjadi SA; Seelig MS; Berger AR; Milstoc M
    Am J Nephrol; 1985; 5(3):212-6. PubMed ID: 4014326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.